In addition, no significant difference (P > .05) was observed in the proportion of CD4+CD25+FOXP3+ Treg cells between older (≥60 years of age) and younger HCC patients (<60 years of age). This evidence concerns the gene FOXP3 and hepatocellular carcinoma.